Dialysis access monitoring using a digital stethoscope-based deep learning system - this sbir phase i project will develop a deep learning-based algorithm to analyze the sound of blood flow in newly…
Ended Project Grant Awarded Last action
- Award ID
- R43DK129107
- Recipient
-
EKO Health, Inc. UEI GM3UL6PBJKD3
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $837,194
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Funding
-
- $537,836.48 Federal
- $299,358.00 Non-federal
- Place of performance
- California, USA
Award details come from USAspending.gov.
Description
Dialysis access monitoring using a digital stethoscope-based deep learning system - this sbir phase i project will develop a deep learning-based algorithm to analyze the sound of blood flow in newly created arteriovenous fistulas (avfs) used for hemodialysis access. This monitoring tool can help to identify fistulas that are unlikely to mature in patients who need surgical intervention to achieve successful maturation. The specific aims of the study are (1) to create the world's first deep learning-scale database of newly created AVF sounds from hemodialysis patients, and (2) develop and evaluate the performance of a deep learning classification model trained via semi-supervised learning to discriminate between patients with avfs likely to mature and patients with avfs unlikely to mature. By integrating this deep learning algorithm into EKO's mobile and cloud software platform, we anticipate this algorithm will enable better monitoring of the maturation process for newly created fistulas. During phase i of the project, we will recruit study subjects in access centers at the university of north carolina (UNC).
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$60,880 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $299,358 | $0 | |
| Original award | $299,358 | $299,358 |
Show all 11
Quick answers
Who received award R43DK129107?
R43DK129107 was awarded to EKO Health, Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on June 15, 2021.
How much is award R43DK129107 worth?
$837,194 has been obligated on R43DK129107: $537,836 in federal funding and $299,358 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award